Clinical trial Recruiting at 1 site Interventional Ages 18 to 45

Using a continuous glucose monitor to help young adults manage type 2 diabetes.

Official title: CAPAZ-2D: Continuous Glucose Monitoring to Augment and Personalize Self-Management of Type 2 Diabetes in Hispanic/Latinx Young Adults

Run by San Diego State University · NCT07065721 · Data updated 2026-11-12

This 30-day program gives young adults with type 2 diabetes a wearable continuous glucose monitor to try and see if real-time glucose data helps them notice patterns and manage their blood sugar and daily habits.

More Type 2 Diabetes Mellitus (T2DM) trials

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment45 (estimated)
SponsorSan Diego State University
Academic / other
Locations1 site (San Diego, California)
StatusRecruiting
StartedOctober 2, 2025
Main results expectedDecember 1, 2026
Study endsJanuary 1, 2027
Registry record updatedNovember 9, 2026
Trial IDNCT07065721 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 18–45 years old, diagnosed with type 2 diabetes within the past five years, have no prior wearable CGM experience, own a compatible smartphone, and are fluent in English or Spanish.

Probably not a fit

People with long-standing diabetes beyond five years, prior CGM experience, no compatible smartphone, pregnancy or recent postpartum status, or severe mental illness are unlikely to be eligible or to benefit from this pilot.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This community-engaged, mixed-methods pilot enrolls young adults (ages 18-45) with recent-onset type 2 diabetes to wear a continuous glucose monitor (CGM) for 30 days. The study collects quantitative data from the CGM and linked behavioral trackers (for example, step counts and dietary logs) alongside surveys of self-management behaviors. After the wear period, researchers conduct qualitative interviews to identify barriers and facilitators to CGM use and participants' changes in awareness of glucose patterns. Findings will inform the design of a CGM-based self-management intervention tailored to young adults.

Why it matters

Potential benefit: If successful, this approach could help young adults better recognize glucose patterns, improve daily diabetes self-care, and reduce average blood glucose levels.

How similar studies have gone: Previous studies in adults with type 2 diabetes have shown CGMs can improve glycemic awareness and some outcomes, but using CGMs specifically in young adults with integrated behavioral data and qualitative input is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* adult 18-45 years of age
* diagnosis of type 2 diabetes in the last 5 years, as evidenced in the electronic medical record
* no prior use or experience with wearable CGMs
* possession of a smart phone that is compatible with Dexcom CGM sensors (nearly all smartphones are compatible) and willing to download and utilize the Dexcom CGM app
* fluency in English or Spanish

Exclusion Criteria:

* severe mental illness (e.g., psychosis, suicidal ideation);
* pregnancy or \<6 months postpartum

Where it's running

  • Scripps Health
    San Diego, California, United States
    Recruiting

Study contacts

  • Principal investigator: Jessica L McCurley, PhD MPH — San Diego State University
  • Study coordinator: Jessica L McCurley, PhD, MPH
  • Email: jlmccurley@sdsu.edu
  • Phone: 619-594-2132

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.